Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA.
Department of Pathology, Oregon Health and Science University, Portland, OR, USA.
J Alzheimers Dis. 2018;65(2):659-682. doi: 10.3233/JAD-180179.
Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.
有些个体,在此被称为具有阿尔茨海默病神经病理学但认知功能正常(NDAN),尽管存在淀粉样斑块和 tau 缠结,这是典型的有症状的阿尔茨海默病(AD)。在 NDAN 中,与 AD 不同,毒性淀粉样-β寡聚物不会定位于突触后密度(PSD)。因此,NDAN 中突触对淀粉样-β的抵抗力可能使这些个体尽管存在 AD 样病理学但仍保持认知完整。负责这种抵抗力的机制尚不清楚,了解这种保护性生物过程可能会为 AD 的有效治疗方法的开发揭示新的靶点。本研究使用蛋白质组学方法比较 NDAN、AD 和健康年龄匹配个体的海马突触后密度,以确定这些组特有的蛋白质特征。通过亚细胞分级分离 followed by 2D 凝胶电泳和质谱分析来分析 PSD。我们描述了十五种蛋白质,它们构成了 NDAN PSD 的独特蛋白质组学特征,从而将它们与对照组和 AD 患者区分开来。